266 related articles for article (PubMed ID: 26472125)
1. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R
Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance.
Wang ZL; Li N; Wang P; Tang HH; Han ZL; Song JJ; Li XH; Yu HP; Zhang T; Zhang R; Xu B; Zhang MN; Fang Q; Wang R
Neuropharmacology; 2016 Sep; 108():364-72. PubMed ID: 26970017
[TBL] [Abstract][Full Text] [Related]
3. VF-13, a chimeric peptide of VD-hemopressin(α) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effects.
Xu B; Xiao J; Xu K; Zhang Q; Chen D; Zhang R; Zhang M; Zhu H; Niu J; Zheng T; Li N; Zhang X; Fang Q
Neuropharmacology; 2020 Sep; 175():108178. PubMed ID: 32544481
[TBL] [Abstract][Full Text] [Related]
4. Effects of neuropeptide FF system on CB₁ and CB₂ receptors mediated antinociception in mice.
Fang Q; Han ZL; Li N; Wang ZL; He N; Wang R
Neuropharmacology; 2012 Feb; 62(2):855-64. PubMed ID: 21945715
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide.
Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R
J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201
[TBL] [Abstract][Full Text] [Related]
6. Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
Zhang R; Xu B; Zhang MN; Zhang T; Wang ZL; Zhao G; Zhao GH; Li N; Fang Q; Wang R
Eur J Pharmacol; 2017 Oct; 813():122-129. PubMed ID: 28755985
[TBL] [Abstract][Full Text] [Related]
7. Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice.
Pan JX; Wang ZL; Li N; Han ZL; Li XH; Tang HH; Wang P; Zheng T; Fang Q; Wang R
Neurosci Lett; 2014 Aug; 578():187-91. PubMed ID: 25010019
[TBL] [Abstract][Full Text] [Related]
8. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
Fang Q; Jiang TN; Li N; Han ZL; Wang R
Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide FF and related peptides attenuates warm-, but not cold-water swim stress-induced analgesia in mice.
Li N; Han ZL; Fang Q; Wang ZL; Tang HZ; Ren H; Wang R
Behav Brain Res; 2012 Aug; 233(2):428-33. PubMed ID: 22659392
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of rat VD-hemopressin(α), an α-hemoglobin-derived peptide exhibiting cannabinoid agonist-like effects in mice.
Zheng T; Zhang T; Zhang R; Wang ZL; Han ZL; Li N; Li XH; Zhang MN; Xu B; Yang XL; Fang Q; Wang R
Neuropeptides; 2017 Jun; 63():83-90. PubMed ID: 28010996
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.
Quelven I; Roussin A; Zajac JM
Eur J Pharmacol; 2005 Jan; 508(1-3):107-14. PubMed ID: 15680260
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist.
Fang Q; Wang YQ; He F; Guo J; Guo J; Chen Q; Wang R
Regul Pept; 2008 Apr; 147(1-3):45-51. PubMed ID: 18276024
[TBL] [Abstract][Full Text] [Related]
13. Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice.
Zhang RS; He Z; Jin WD; Wang R
Neurobiol Learn Mem; 2016 Oct; 134 Pt B():264-74. PubMed ID: 27481221
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effects of the endogenous cannabinoid peptide agonist VD-hemopressin(β) in mice.
Wang P; Zheng T; Zhang M; Xu B; Zhang R; Zhang T; Zhao W; Shi X; Zhang Q; Fang Q
Brain Res Bull; 2018 May; 139():48-55. PubMed ID: 29425797
[TBL] [Abstract][Full Text] [Related]
15. CB
Zheng T; Zhang R; Zhang T; Zhang MN; Xu B; Song JJ; Li N; Tang HH; Wang P; Wang R; Fang Q
Brain Res; 2018 Feb; 1680():155-164. PubMed ID: 29274880
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide VF Enhances Cannabinoid Agonist WIN55,212-2-Induced Antinociception in Mice.
Han ZL; Wang ZL; Li XH; Li N; Pan JX; Zheng T; Fang Q; Wang R
Anesth Analg; 2015 Nov; 121(5):1360-8. PubMed ID: 26273748
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide FF analog RF9 is not an antagonist of NPFF receptor and decreases food intake in mice after its central and peripheral administration.
Maletínská L; Tichá A; Nagelová V; Spolcová A; Blechová M; Elbert T; Zelezná B
Brain Res; 2013 Mar; 1498():33-40. PubMed ID: 23291266
[TBL] [Abstract][Full Text] [Related]
18. BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice.
Li N; Han ZL; Wang ZL; Xing YH; Sun YL; Li XH; Song JJ; Zhang T; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
Br J Pharmacol; 2016 Jun; 173(11):1864-80. PubMed ID: 27018797
[TBL] [Abstract][Full Text] [Related]
19. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
Gouardères C; Jhamandas K; Sutak M; Zajac JM
Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice.
Wang YQ; Guo J; Wang SB; Fang Q; He F; Wang R
Peptides; 2008 Jul; 29(7):1183-90. PubMed ID: 18406009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
